Phase 4
Completed N=57
Postoperative Pain Control Following Vitreoretinal Surgery
Retinal Detachment · Proliferative Vitreoretinopathy · Retinoschisis
Source: ClinicalTrials.gov NCT01995045 ↗
Enrolled (actual)
57
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: Mean Pain Score — 2.9; 3.8 units on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Pain Score |
2.9; 3.8 | — |
| SECONDARY Mean Acetaminophen Intake |
819; 962 | — |
| SECONDARY Mean Hydrocodone Intake |
.7; 2.8 | — |
| SECONDARY Mean Oxycodone Intake |
6.7; 9.0 | — |
Eligibility Criteria
Inclusion Criteria
- Patients undergoing vitreoretinal surgery at the Emory Eye Center Ambulatory Surgery Center and Emory University Hospital by retina attending faculty surgeons
Exclusion Criteria
- Unable to verbalize level of pain control
- Pediatric patients (<18 years old)
- Glaucoma, ocular hypertension, or glaucoma suspects
- Allergy to local anesthetic
- Pre-existing chronic pain requiring narcotic pain medication
- Drug addiction
- Impaired periorbital sensation (history of herpes simplex, zoster, corneal graft)
Data sourced from ClinicalTrials.gov (NCT01995045). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.